Lundbeck
HLUN-B.CO
#2578
Rank
โ‚ฌ5.24 B
Marketcap
5,50ย โ‚ฌ
Share price
0.59%
Change (1 day)
27.25%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : โ‚ฌ2.23 Billion

According to Lundbeck 's latest financial reports the company's total liabilities are โ‚ฌ2.23 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Lundbeck - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚ฌ2.05 B-8.05%
2022-12-31โ‚ฌ2.23 B1.69%
2021-12-31โ‚ฌ2.20 B-14.05%
2020-12-31โ‚ฌ2.56 B-10.38%
2019-12-31โ‚ฌ2.85 B143.58%
2018-12-31โ‚ฌ1.17 B15.27%
2017-12-31โ‚ฌ1.01 B-28.1%
2016-12-31โ‚ฌ1.41 B-15.78%
2015-12-31โ‚ฌ1.68 B3.34%
2014-12-31โ‚ฌ1.62 B19.31%
2013-12-31โ‚ฌ1.36 B21.57%
2012-12-31โ‚ฌ1.12 B7.75%
2011-12-31โ‚ฌ1.04 B12.69%
2010-12-31โ‚ฌ0.92 B-17.49%
2009-12-31โ‚ฌ1.11 B66.15%
2008-12-31โ‚ฌ0.67 B-2.24%
2007-12-31โ‚ฌ0.68 B5.38%
2006-12-31โ‚ฌ0.65 B18.28%
2005-12-31โ‚ฌ0.55 B12.26%
2004-12-31โ‚ฌ0.49 B